Saturday 17 October 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
12.66
0.25
−1.94%
Follow CC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 4 | 4 |
| (70.49%) | (93.80%) | (103.02%) | (318.32%) | ||
| (4.50%) | (5.18%) | (5.59%) | (4.15%) | ||
ROIC |
0.24% | (1.08%) | (1.50%) | (2.22%) | |
Return on Tangible Assets |
(7.65%) | (8.79%) | (9.41%) | (7.13%) | |
Average Days of Receivables |
59.23 | 42.67 | 47.59 | 57.11 | |
Free Cash Flow per Share |
(0.05) | 0.34 | 1.02 | 1.44 | |
Free Cash Flow |
(8.00) | 51.00 | 154.00 | 218.00 | |
Capital Expenditures |
(273.00) | (213.00) | (178.00) | (179.00) | |
| Other line items | |||||
Cash ROIC |
(0.16%) | 1.01% | 3.13% | 4.85% | |
Accounts Receivable Turnover |
6.15 | 8.02 | 7.20 | 6.21 | |
Accounts Payable Turnover |
4.59 | 4.65 | 5.21 | 5.01 | |
Inventory Turnover |
3.23 | 3.24 | 3.20 | 3.26 | |
Average Days of Payables |
78.30 | 70.98 | 65.79 | 69.64 | |
Days of Inventory on Hand |
117.03 | 116.73 | 113.42 | 107.92 | |
Tax Rate |
0.70 | 0.39 | 0.37 | 4.87 | |
Research and Development Expense of Revenue |
1.83% | 1.86% | 1.84% | 1.83% | |
Selling, General and Administrative Expense of Revenue |
14.15% | 13.76% | 14.14% | 14.97% | |
Share Based Compensation of Revenue |
0.34% | 0.36% | 0.40% | 0.40% | |
Interest Coverage |
0.06 | (0.24) | (0.33) | (0.41) | |
Operating CF/Net income |
(0.78) | (0.68) | (0.81) | (1.31) | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.11 | 0.11 | |
Capex/Depreciation |
(0.79) | (0.61) | (0.52) | (0.54) | |
Revenue per Share |
38.82 | 38.66 | 38.61 | 38.33 | |
Operating CF per Share |
1.76 | 1.76 | 2.20 | 2.63 | |
Capex per Share |
(1.82) | (1.42) | (1.18) | (1.18) | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.03 |
Columns are period end dates